We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy
NAUT

81 hedge funds and large institutions have $82.9M invested in Nautilus Biotechnolgy in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 20

6% less funds holding

Funds holding: 86 → 81 (-5)

8.34% less ownership

Funds ownership: 45.28% → 36.93% (-8.3%)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

31% less capital invested

Capital invested by funds: $120M → $82.9M (-$36.7M)

Holders
81
Holders Change
-5
Holders Change %
-5.81%
% of All Funds
1.3%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
11
Increased
20
Reduced
20
Closed
14
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$868K
2
BlackRock
BlackRock
New York
+$264K
3
CGL
Clarius Group LLC
Washington
+$160K
4
Morgan Stanley
Morgan Stanley
New York
+$145K
5
State Street
State Street
Massachusetts
+$96.3K

Top Sellers

Rank Fund Capital Flow
1
ABG
Ally Bridge Group
New York
-$1.28M
2
BM
Bridger Management
New York
-$877K
3
AAA
Affinity Asset Advisors
New York
-$790K
4
NCM
Nantahala Capital Management
Connecticut
-$706K
5
SGM
Skye Global Management
Florida
-$331K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$16.4M – – –
CM
2
Cercano Management
Washington
$12.9M +$13.8M +7,172,985 New
MVG
3
Madrona Venture Group
Washington
$10.8M – – –
BlackRock
4
BlackRock
New York
$6.02M +$264K +136,829 +4%
CFM
5
Comprehensive Financial Management
California
$4M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.92M -$2.53K -1,313 -0.1%
BCLSI
7
Bain Capital Life Sciences Investors
Massachusetts
$3.6M – – –
TM
8
Tikvah Management
North Carolina
$2.68M – – –
ACI
9
Amazon.com Inc
Washington
$2.62M – – –
AI
10
ArchPoint Investors
Florida
$2.61M – – –
AEPLI
11
AH Equity Partners LSV II
California
$2.44M – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.73M +$11.2K +5,799 +0.6%
RCMNY
13
Rubric Capital Management (New York)
New York
$1.35M – – –
State Street
14
State Street
Massachusetts
$1.26M +$96.3K +49,879 +8%
RI
15
RTW Investments
New York
$1.08M – – –
CGL
16
Clarius Group LLC
Washington
$1.06M +$160K +82,901 +16%
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$858K – – –
AFM
18
Anson Funds Management
Texas
$809K +$868K +449,516 New
Northern Trust
19
Northern Trust
Illinois
$798K -$3.44K -1,784 -0.4%
Morgan Stanley
20
Morgan Stanley
New York
$669K +$145K +75,359 +25%
DCMIC
21
Decheng Capital Management III (Cayman)
Cayman Islands
$540K – – –
NCM
22
Nantahala Capital Management
Connecticut
$522K -$706K -365,493 -56%
CC
23
Clearline Capital
New York
$477K – – –
HC
24
Hillman Company
Pennsylvania
$360K – – –
ST
25
Sentinel Trust
Texas
$333K -$57.9K -30,000 -14%
1
2 3 4

NAUT Hedge Fund Activity: Q4 2022 in Review

81 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q4 2022, worth a combined $82.9M — down 31% from $120M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of NAUT and 11 opened new positions — a net loss of 3 holders — while 20 trimmed existing stakes and 20 added.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $868K. The largest seller was Ally Bridge Group, cutting an estimated $1.28M.

  • 81 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q4 2022, down from 86 in Q3 2022.
  • Funds reported $82.9M of Nautilus Biotechnolgy stock for Q4 2022, down 31% quarter-over-quarter.
  • 11 funds opened new Nautilus Biotechnolgy positions in Q4 2022 and 14 closed out, a net change of -3 holders.
  • The largest Nautilus Biotechnolgy buyer in Q4 2022 was Anson Funds Management, an estimated $868K added.
  • The largest Nautilus Biotechnolgy seller in Q4 2022 was Ally Bridge Group, an estimated $1.28M sold.

Based on aggregated 13F filings for Q4 2022.